Siemens Healthineers has started worldwide shipping of a laboratory-based total Covid-19 antibody test to detect the presence of SARS-CoV-2 IgM and IgG antibodies in the blood.
The CE-marked test has demonstrated 100% sensitivity and 99.8% specificity.
It helps to identify patients who have developed an adaptive immune response because of a recent infection or prior exposure.
Siemens Healthineers is prepared to scale up production at its Walpole, UK, and Glasgow, Scotland, facilities, with a capacity of over 50 million tests a month, beginning in June.